Pfizer planning yet another plant expansion

In yet another expansion of its manufacturing operations, Pfizer ($PFE) plans to lay out nearly $150 million to build a sterile manufacturing facility and warehouse at its site near Kalamazoo, MI. It is the third manufacturing project the drug giant has unveiled in the last couple of months.

The New York-based drugmaker intends to invest about $105.6 million on a sterile manufacturing operation and another $40.8 million on a warehouse, Michigan Live reports. The projects, for which Pfizer is seeking tax breaks, are expected to add only about 15 jobs but are part of about $800 million in investments the company has told the city could come over the next decade. It indicated it has invested about that much at the site in the last 10 years.

Pfizer site leader Robert Betzig told WKZO radio that the new technology investments will help the Pfizer site stay competitive with plants in low-cost countries like India and China.

Whitepaper

Simplify and Accelerate Drug R&D With the MarkLogic Data Hub Service for Pharma R&D

Researchers are often unable to access the information they need. And, even when data does get consolidated, researchers find it difficult to sift through it all and make sense of it in order to confidently draw the right conclusions and share the right results. Discover how to quickly and easily find, synthesize, and share information—accelerating and improving R&D.

The 2,000-acre site in Kalamazoo County produces sterile injectables, nonsterile medications, biologicals, and other products, as well as 150 active pharmaceutical ingredients, steroids, antibiotics, and other Pfizer drugs, the company’s website indicates. It has about 2,100 employees at the site.

Pfizer is also seeking approval by authorities in Dublin, Ireland, to invest between €300 million and €400 million ($440.5 million) to build a 5-story, 34,500-square-meter (371,354-square-foot) biologics manufacturing unit at its Grange Castle manufacturing site. That  project is slated to result in 350 jobs and provide additional capacity for Pfizer arthritis drug Enbrel.

In June, Pfizer said it would spend $200 million to build a 175,000-square-foot facility at its campus in Andover, MA, also to produce complex biologics and vaccines.

- read the Michigan Live story
- get more from WKZO radio

Related Articles:
Pfizer expansion in Ireland would lead to 350 jobs
Pfizer planning Ireland biologics plant expansion
Pfizer adding $200M biologics facility to Andover, MA, campus

Read more on

Suggested Articles

Fujifilm has completed the first manufacturing facility in Japan to make drug-delivering liposomes to use for cancer fighting drugs it is developing.

Three Samsung execs face up to two years in jail for their roles in destroying data and documents at under-fire affiliate Samsung BioLogics.

The FDA has slapped a U.S. drug repackager, saying in a warning letter that its storage processes and equipment cleaning are not up to expectations.